MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$17,975K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of shor...
Change in fair value of warrant ...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of short-term investme...
Net (loss) income
Payments of long-term debt
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Gain on disposal of property and equipment
-
-
0
-
Other current liabilities
-
-
-23
0
Restricted cash
0
-
-
-
Change in payable to licensor
-
7,000
0
-
Net (loss) income
-20,191
-17,075
-20,460
-5,161
Depreciation and amortization
665
690
863
608
Stock-based compensation expense
3,369
2,957
2,559
2,689
Change in fair value of warrant liabilities
7,191
-5,386
-1,522
-2,760
Accretion and interest on short-term investments
-77
-13
-687
88
Amortization of right-of-use lease assets
168
179
229
280
Non-cash interest
235
274
284
270
Gain from sale of priority review voucher
-
-
0
0
Accounts receivable
3,194
53
6,147
-
Inventory
-133
561
643
2,164
Other receivables
-14
-59
-1,048
-14
Prepaid expenses and other current assets
-9
657
-915
119
Other assets
0
46
240
203
Accounts payable and accrued expenses
978
-7,315
4,238
1,001
Lease liabilities
-202
-182
472
-381
Deferred revenue
252
425
-
-
Accrued taxes and other current liabilities
0
-126
-213
-15,173
Net cash used in operating activities
-17,496
-19,804
-17,953
-21,187
Proceeds from disposal of property and equipment
-
-
0
-
Proceeds from sale of priority review voucher, net of transaction costs of 2.6 million
-
-
0
0
Capital expenditures
479
935
1,153
2,520
Purchases of short-term investments
24,706
19,000
37,784
100,351
Proceeds from maturities of short-term investments
40,871
24,898
48,491
38,244
Net cash provided by investing activities
15,686
4,963
9,554
-64,627
Proceeds from underwritten sales of common stock, net of issuance costs
-
-
0
-
Proceeds from issuance of long-term debt
-
-
0
-
Payment of debt issuance costs
-
-
0
-
Proceeds from atm sales of common stock, net of issuance costs
-
-
0
0
Payments related to net settlement of restricted share awards
1
-
0
-37
Proceeds from exercise of warrants
-
-
3,614
5,163
Payments of long-term debt
3,334
2,222
-
-
Net cash (used in) provided by financing activities
-3,335
-2,222
3,614
5,163
Net (decrease) increase in cash, cash equivalents and restricted cash
-5,145
-17,063
-4,785
-80,651
Cash, cash equivalents and restricted cash at beginning of period
83,222
83,222
-
23,695
Cash, cash equivalents and restricted cash at end of period
56,229
61,374
-
83,222
Cash and cash equivalents
56,229
-
-
-
Total cash, cash equivalents and restricted cash
56,229
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of short-term...
$40,871K
(-49.25%↓ Y/Y)
Net cash provided by
investing activities
$15,686K
(-90.20%↓ Y/Y)
Canceled cashflow
$25,185K
Net (decrease)
increase in cash, cash...
-$5,145K
(-103.67%↓ Y/Y)
Canceled cashflow
$15,686K
Change in fair value of
warrant liabilities
$7,191K
(487.24%↑ Y/Y)
Stock-based compensation
expense
$3,369K
(-39.09%↓ Y/Y)
Accounts payable and
accrued expenses
$978K
(-24.83%↓ Y/Y)
Depreciation and
amortization
$665K
(-38.31%↓ Y/Y)
Deferred revenue
$252K
Non-cash interest
$235K
(-60.70%↓ Y/Y)
Amortization of right-of-use
lease assets
$168K
(-66.73%↓ Y/Y)
Inventory
-$133K
(-104.95%↓ Y/Y)
Accretion and interest on
short-term investments
-$77K
(73.45%↑ Y/Y)
Other receivables
-$14K
(36.36%↑ Y/Y)
Prepaid expenses and
other current assets
-$9K
(-100.95%↓ Y/Y)
Purchases of short-term
investments
$24,706K
(-63.93%↓ Y/Y)
Capital expenditures
$479K
(-88.87%↓ Y/Y)
Net cash used in
operating activities
-$17,496K
(52.95%↑ Y/Y)
Canceled cashflow
$13,091K
Net cash (used in)
provided by financing...
-$3,335K
(-119.32%↓ Y/Y)
Net (loss) income
-$20,191K
(-120.86%↓ Y/Y)
something is missing
-$7,000K
Accounts receivable
$3,194K
Lease liabilities
-$202K
(69.72%↑ Y/Y)
Payments of long-term
debt
$3,334K
Payments related to net
settlement of restricted...
$1K
(102.70%↑ Y/Y)
Buy us a coffee
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)